Package 0591-3541-05

{"route": ["ORAL"], "spl_id": "46100e89-6164-4144-8f8b-761371282a01", "openfda": {"unii": ["ZG7E5POY8O"], "rxcui": ["993503", "993518", "993536"], "spl_set_id": ["cec41945-8d64-4793-8784-4c2b8ec37b0f"], "manufacturer_name": ["Actavis Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-05)", "package_ndc": "0591-3541-05", "marketing_start_date": "20090702"}, {"sample": false, "description": "250 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-25)", "package_ndc": "0591-3541-25", "marketing_start_date": "20090702"}, {"sample": false, "description": "60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (0591-3541-60)", "package_ndc": "0591-3541-60", "marketing_start_date": "20090702"}], "brand_name": "Bupropion Hydrochloride SR", "product_id": "0591-3541_46100e89-6164-4144-8f8b-761371282a01", "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE", "pharm_class": ["Aminoketone [EPC]", "Dopamine Uptake Inhibitors [MoA]", "Increased Dopamine Activity [PE]", "Increased Norepinephrine Activity [PE]", "Norepinephrine Uptake Inhibitors [MoA]"], "product_ndc": "0591-3541", "generic_name": "bupropion hydrochloride", "labeler_name": "Actavis Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Bupropion Hydrochloride", "brand_name_suffix": "SR", "active_ingredients": [{"name": "BUPROPION HYDROCHLORIDE", "strength": "150 mg/1"}], "application_number": "ANDA079095", "marketing_category": "ANDA", "marketing_start_date": "20090702", "listing_expiration_date": "20271231"}